Post-translational modification of α-synuclein in Parkinson's disease

Brain Research

Volumn 1628, Issue , 2015, Pages 247-253

  Barrett, Paul J ^a   Timothy Greenamyre, J ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Alpha synuclein; Lewy body; Lewy neurite; Oxidative stress; Parkinson's disease; Post translational modification

Indexed keywords

ALPHA SYNUCLEIN; DOPAMINE; REACTIVE OXYGEN METABOLITE;

ARTICLE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DOPAMINERGIC NERVE CELL; NEUROTOXICITY; NITRATION; PARKINSON DISEASE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; ANIMAL; BRAIN; HUMAN; METABOLISM; PATHOLOGY; PHYSIOLOGY;

ALPHA-SYNUCLEIN; ANIMALS; BRAIN; HUMANS; PARKINSON DISEASE; PROTEIN PROCESSING, POST-TRANSLATIONAL;

EID: 84952637945     PISSN: 00068993     EISSN: 18726240     Source Type: Journal    
DOI: 10.1016/j.brainres.2015.06.002     Document Type: Article

References (52)

1. Z. Alam, A. Jenner, S. Daniel, A. Lees, N. Cairns, C. Marsden, and et al. Oxidative DNA damage in the parkinsonian brain: an apparent selective increase in 8-Hydroxyguanine Levels in Substantia Nigra J. Neurochem. 69 3 1997 1196 1203
2. J.P. Anderson, D.E. Walker, J.M. Goldstein, R. de Laat, K. Banducci, R.J. Caccavello, and et al. Phosphorylation of Ser-129 is the dominant pathological modification of α-synuclein in familial and sporadic Lewy body disease J. Biol. Chem. 281 40 2006 29739 29752
3. T. Bartels, J.G. Choi, and D.J. Selkoe [agr]-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation Nature 477 7362 2011 107 110
4. S.B. Berman, and T.G. Hastings Dopamine oxidation alters mitochondrial respiration and induces permeability transition in brain mitochondria: implications for Parkinson's disease J. Neurochem. 73 3 1999 1127 1137 PubMed PMID: 10461904
5. J. Burre, M. Sharma, T. Tsetsenis, V. Buchman, M.R. Etherton, and T.C. Sudhof Alpha-synuclein promotes SNARE-complex assembly in vivo and in vitro PubMed PMID: 20798282; PubMed Central PMCID: PMC3235365 Science 329 5999 2010 1663 1667 10.1126/science.1195227
6. R. Cappai, S.-L. Leck, D.J. Tew, N.A. Williamson, D.P. Smith, D. Galatis, and et al. Dopamine promotes α-synuclein aggregation into SDS-resistant soluble oligomers via a distinct folding pathway FASEB J. 19 10 2005 1377 1379
7. L. Chen, and M.B. Feany α-Synuclein phosphorylation controls neurotoxicity and inclusion formation in a Drosophila model of Parkinson disease Nat. Neurosci. 8 5 2005 657 663
8. L. Chen, M. Periquet, X. Wang, A. Negro, P.J. McLean, B.T. Hyman, and et al. Tyrosine and serine phosphorylation of α-synuclein have opposing effects on neurotoxicity and soluble oligomer formation J. Clin. Investig. 119 11 2009 3257
9. K.A. Conway, J.-C. Rochet, R.M. Bieganski, and P.T. Lansbury Kinetic stabilization of the α-synuclein protofibril by a dopamine-α-synuclein adduct Science 294 5545 2001 1346 1349
10. L. Devi, V. Raghavendran, B.M. Prabhu, N.G. Avadhani, and H.K. Anandatheerthavarada Mitochondrial import and accumulation of alpha-synuclein impair complex I in human dopaminergic neuronal cultures and Parkinson disease brain J. Biol. Chem. 283 14 2008 9089 9100 Epub 2008/02/05. doi: M710012200 [pii]10.1074/jbc.M710012200. PubMed PMID: 18245082; PubMed Central PMCID: PMC2431021
11. L. Devi, V. Raghavendran, B.M. Prabhu, N.G. Avadhani, and H.K. Anandatheerthavarada Mitochondrial import and accumulation of α-synuclein impair complex I in human dopaminergic neuronal cultures and Parkinson disease brain J. Biol. Chem. 283 14 2008 9089 9100
12. D. Dexter, C. Carter, F. Wells, F. Javoy-Agid, Y. Agid, A. Lees, and et al. Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease J. Neurochem. 52 2 1989 381 389
13. E. Floor, and M.G. Wetzel Increased protein oxidation in human substantia nigra pars compacta in comparison with basal ganglia and prefrontal cortex measured with an improved dinitrophenylhydrazine assay J. Neurochem. 70 1 1998 268 275
14. H. Fujiwara, M. Hasegawa, N. Dohmae, A. Kawashima, E. Masliah, M.S. Goldberg, and et al. α-Synuclein is phosphorylated in synucleinopathy lesions Nat. Cell Biol. 4 2 2002 160 164
15. B.I. Giasson, J.E. Duda, Murray IV, Q. Chen, J.M. Souza, H.I. Hurtig, and et al. Oxidative damage linked to neurodegeneration by selective alpha- synuclein nitration in synucleinopathy lesions [In Process Citation] Science 290 5493 2000 985 989 PubMed PMID: 0011062131
16. P.F. Good, A. Hsu, P. Werner, D.P. Perl, and C.W. Olanow Protein nitration in Parkinson's disease J. Neuropathol. Exp. Neurol. 57 4 1998 338 342 PubMed PMID: 9600227
17. D.G. Graham Oxidative pathways for catecholamines in the genesis of neuromelanin and cytotoxic quinones Mol. Pharmacol. 14 4 1978 633 643 PubMed PMID: 98706
18. J.M. Hatcher, K.D. Pennell, and G.W. Miller Parkinson's disease and pesticides: a toxicological perspective doi: S0165-6147(08)00082-5 [pii]10.1016/j.tips.2008.03.007. PubMed PMID: 18453001 Trends Pharmacol. Sci. 29 6 2008 322 329 Epub 2008/05/03
19. R. Hodara, E.H. Norris, B.I. Giasson, A.J. Mishizen-Eberz, D.R. Lynch, V.M. Lee, and et al. Functional consequences of alpha-synuclein tyrosine nitration: diminished binding to lipid vesicles and increased fibril formation J. Biol. Chem. 279 46 2004 47746 47753 10.1074/jbc.M408906200 PubMed PMID: 15364911
20. M.P. Horowitz, C. Milanese, R. Di Maio, X. Hu, L.M. Montero, L.H. Sanders, and et al. Single-cell redox imaging demonstrates a distinctive response of dopaminergic neurons to oxidative insults Antioxid. Redox Signal. 15 4 2011 855 871 10.1089/ars.2010.3629 PubMed PMID: 21395478; PubMed Central PMCID: PMC3135271
21. L.J. Hsu, Y. Sagara, A. Arroyo, E. Rockenstein, A. Sisk, M. Mallory, and et al. α-Synuclein promotes mitochondrial deficit and oxidative stress Am. J. Pathol. 157 2 2000 401 410
22. K.S. Kim, S.Y. Choi, H.Y. Kwon, M.H. Won, T.-C. Kang, and J.H. Kang Aggregation of α-synuclein induced by the Cu, Zn-superoxide dismutase and hydrogen peroxide system Free Rad. Biol. Med. 32 6 2002 544 550
23. M.J. LaVoie, B.L. Ostaszewski, A. Weihofen, M.G. Schlossmacher, and D.J. Selkoe Dopamine covalently modifies and functionally inactivates parkin Nat. Med. 11 11 2005 1214 1221
24. S.L. Leong, R. Cappai, K.J. Barnham, and C.L. Pham Modulation of alpha-synuclein aggregation by dopamine: a review Neurochem. Res. 34 10 2009 1838 1846 10.1007/s11064-009-9986-8 PubMed PMID: 19444607
25. J. Li, M. Zhu, A.B. Manning-Bog, D.A. Di Monte, and A.L. Fink Dopamine and l-dopa disaggregate amyloid fibrils: implications for Parkinson's and Alzheimer's disease FASEB J. 18 9 2004 962 964
26. D.A. Linseman, B.D. Butts, T.A. Precht, R.A. Phelps, S.S. Le, T.A. Laessig, and et al. Glycogen synthase kinase-3β phosphorylates Bax and promotes its mitochondrial localization during neuronal apoptosis J. Neurosci. 24 44 2004 9993 10002
27. Lotharius J., Barg S., Wiekop P., Lundberg C., Raymon H.K., Brundin P. Effect of mutant alpha-synuclein on dopamine homeostasis in a new human mesencephalic cell line. The Journal of Biological Chemistry. 2002;277(41):38884-94. Epub 2002/07/30. 10.1074/jbc.M205518200. PubMed PMID: 12145295.
28. K.C. Luk, V. Kehm, J. Carroll, B. Zhang, P. O'Brien, J.Q. Trojanowski, and et al. Pathological α-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice Science 338 6109 2012 949 953
29. 2+-induced Mitochondrial Dysfunction J. Biol. Chem. 289 31 2014 21490 21507
30. E.S. Luth, T. Bartels, U. Dettmer, N.C. Kim, and D.J. Selkoe Purification of alpha-synuclein from human brain reveals an instability of endogenous multimers as the protein approaches purity Biochemistry 54 2 2015 279 292 10.1021/bi501188a PubMed PMID: 25490121; PubMed Central PMCID: PMC4303315
31. L. Maroteaux, J.T. Campanelli, and R.H. Scheller Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal J. Neurosci. 8 8 1988 2804 2815
32. J.R. Mazzulli, A.J. Mishizen, B.I. Giasson, D.R. Lynch, S.A. Thomas, A. Nakashima, and et al. Cytosolic catechols inhibit α-synuclein aggregation and facilitate the formation of intracellular soluble oligomeric intermediates J. Neurosci. 26 39 2006 10068 10078
33. M.K. Mbefo, K.E. Paleologou, A. Boucharaba, A. Oueslati, H. Schell, M. Fournier, and et al. Phosphorylation of synucleins by members of the Polo-like kinase family J. Biol. Chem. 285 4 2010 2807 2822
34. E.H. Norris, B.I. Giasson, R. Hodara, S. Xu, J.Q. Trojanowski, H. Ischiropoulos, and et al. Reversible inhibition of alpha-synuclein fibrillization by dopaminochrome-mediated conformational alterations PubMed PMID: 15817478 J. Biol. Chem. 280 22 2005 10.1074/jbc.M412621200 21212-9. Epub 2005/04/09
35. A. Oueslati, M. Fournier, and H.A. Lashuel Role of post-translational modifications in modulating the structure, function and toxicity of alpha-synuclein: implications for Parkinson's disease pathogenesis and therapies Prog. Brain Res. 183 2010 115 145 10.1016/S0079-6123(10)83007-9 PubMed PMID: 20696318
36. D.J. Pagliarini, and J.E. Dixon Mitochondrial modulation: reversible phosphorylation takes center stage? Trends Biochem. Sci. 31 1 2006 26 34
37. M.H. Polymeropoulos, C. Lavedan, E. Leroy, S.E. Ide, A. Dehejia, A. Dutra, and et al. Mutation in the α-synuclein gene identified in families with Parkinson's disease Science 276 5321 1997 2045 2047
38. A. Rekas, R.B. Knott, A. Sokolova, K.J. Barnham, K.A. Perez, C.L. Masters, and et al. The structure of dopamine induced alpha-synuclein oligomers Eur. Biophys. J.: EBJ 39 10 2010 1407 1419 10.1007/s00249-010-0595-x PubMed PMID: 20309679
39. M.-A. Robin, S.K. Prabu, H. Raza, H.K. Anandatheerthavarada, and N.G. Avadhani Phosphorylation enhances mitochondrial targeting of GSTA4-4 through increased affinity for binding to cytoplasmic Hsp70 J. Biol. Chem. 278 21 2003 18960 18970
40. L.H. Sanders, J. McCoy, X. Hu, P.G. Mastroberardino, B.C. Dickinson, C.J. Chang, and et al. Mitochondrial DNA damage: molecular marker of vulnerable nigral neurons in Parkinson's disease Neurobiol. Dis. 70 2014 214 223 10.1016/j.nbd.2014.06.014 PubMed PMID: 24981012; PubMed Central PMCID: PMC4144978
41. T.B. Sherer, R. Betarbet, A.K. Stout, S. Lund, M. Baptista, A.V. Panov, and et al. An in vitro model of Parkinson's disease: linking mitochondrial impairment to altered alpha-synuclein metabolism and oxidative damage J. Neurosci. 22 16 2002 7006 7015 PubMed PMID: 12177198
42. S.A. da Silveira, B.L. Schneider, C. Cifuentes-Diaz, D. Sage, T. Abbas-Terki, T. Iwatsubo, and et al. Phosphorylation does not prompt, nor prevent, the formation of α-synuclein toxic species in a rat model of Parkinson's disease Hum. Mol. Genet. 18 5 2009 872 887
43. A. Singleton, M. Farrer, J. Johnson, A. Singleton, S. Hague, J. Kachergus, and et al. α-Synuclein locus triplication causes Parkinson's disease Science 302 5646 2003 841
44. W.W. Smith, R.L. Margolis, X. Li, J.C. Troncoso, M.K. Lee, V.L. Dawson, and et al. α-Synuclein phosphorylation enhances eosinophilic cytoplasmic inclusion formation in SH-SY5Y cells J. Neurosci. 25 23 2005 5544 5552
45. J.M. Souza, B.I. Giasson, Q. Chen, V.M. Lee, and H. Ischiropoulos Dityrosine cross-linking promotes formation of stable alpha -synuclein polymers. Implication of nitrative and oxidative stress in the pathogenesis of neurodegenerative synucleinopathies J. Biol. Chem. 275 24 2000 18344 18349 10.1074/jbc.M000206200 PubMed PMID: 10747881
46. N. Sugeno, A. Takeda, T. Hasegawa, M. Kobayashi, A. Kikuchi, F. Mori, and et al. Serine 129 phosphorylation of alpha-synuclein induces unfolded protein response-mediated cell death J. Biol. Chem. 283 34 2008 23179 23188 10.1074/jbc.M802223200 PubMed PMID: 18562315
47. T.S. Ulmer, A. Bax, N.B. Cole, and R.L. Nussbaum Structure and dynamics of micelle-bound human α-synuclein J. Biol. Chem. 280 10 2005 9595 9603
48. M.J. Volles, and P.T. Lansbury Jr. Vesicle permeabilization by protofibrillar alpha-synuclein is sensitive to Parkinson's disease-linked mutations and occurs by a pore-like mechanism Biochemistry 41 14 2002 4595 4602 PubMed PMID: 11926821
49. M.J. Volles, and P.T. Lansbury Vesicle permeabilization by protofibrillar α-synuclein is sensitive to Parkinson's disease-linked mutations and occurs by a pore-like mechanism Biochemistry 41 14 2002 4595 4602
50. W. Wang, I. Perovic, J. Chittuluru, A. Kaganovich, L.T. Nguyen, J. Liao, and et al. A soluble α-synuclein construct forms a dynamic tetramer Proc. Natl. Acad. Sci. 108 43 2011 17797 17802
51. J. Xu, S.-Y. Kao, F.J. Lee, W. Song, L.-W. Jin, and B.A. Yankner Dopamine-dependent neurotoxicity of α-synuclein: a mechanism for selective neurodegeneration in Parkinson disease Nat. Med. 8 6 2002 600 606
52. G. Yamin, V.N. Uversky, and A.L. Fink Nitration inhibits fibrillation of human alpha-synuclein in vitro by formation of soluble oligomers FEBS Lett. 542 1-3 2003 147 152 PubMed PMID: 12729915